@alkpositiveuk
💙 Supporting, empowering & advocating for those with ALK+ lung cancer in the UK 🧬 Advocacy | Awareness | Trusted resources 🫶 NICE-recognised, improving lives, driving change, and amplifying our community voices linktr.ee/alkpositivelungcanceruk
Repeat chest infections can be an overlooked sign of #lungcancer.
Prof Robert Rintoul says slow clearing or repeat chest infections, should raise concern.
Finding lung cancer early is key to better outcomes, so awareness of less obvious symptoms is key. #LCSM
www.telegraph.co.uk/health-fitne...
photo of the 1970 march showing a crowd of women and the banner ‘women of the world unite’
Giving thanks for all amazing and inspiring women around the world on International Women’s Day
We will never give up fighting for equality, for what is just and fair, and for each other 💪
#WomenOfTheWorldUnite
#WomenInScience 🧪
International Women’s Day Highlights 2026: Honoring Women in Oncology
@erikahamilton9.bsky.social @elinardou.bsky.social @latinamd.bsky.social @lilliansiu.bsky.social
oncodaily.com/not-to-miss/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IWD2026
Lung cancer is rising in young, non-smoking women yet many face misdiagnosis & delays, because it isn’t expected in people their age.
This #InternationalWomensDay, let’s make #lungcancer in young, non-smoking women part of the conversation.
🙏 to our ALK+ UK commmunity for sharing their stories.
Call for Expressions of Interest for Clinical Oncology and Surgery Representation on the BTOG Steering Committee:
Learn more: https://www.btog.org/join-the-btog-steering-committee/
Deadline for submission of expression of interest is Monday 9th March 2026.
#LCSM #LungCancer
At @btog.bsky.social 2026 clinicians shared real world experience managing side effects from lorlatinib in ALK+ #lungcancer.
As people stay on targeted therapy for years, practical strategies like dose adjustment and careful monitoring are becoming central to long term care. #LCSM
🚀New NLCA blog: State of the Nation 2026: progress in earlier diagnosis and the challenge of rising demand
By Dr Lauren Dixon, NLCA Clinical Fellow
📌More people diagnosed earlier
📌Growing demand and pressure on services
Read the blog here👉 buff.ly/3qrBYu1
@btog.bsky.social @lcnuk.bsky.social
Day 2 at #BTOG26.
ALK Positive UK is in Edinburgh alongside EGFR+ UK & the Ruth Strauss Foundation.
A packed programme of #lungcancer science, trials & debate plus an important chance for charities to connect directly with the clinicians & researchers influencing care.
#LCSM
NEW PAPER: Our decision-modelling study showed specialist palliative care in England (home and hospital) saved £817M, freed 1.5M hospital bed days, helped 20,000+ people die outside hospital and improved quality of life. #palliativecare #palliativemedicine
At @btog.bsky.social 2026 we’re sharing an evaluation of the See Through the Symptoms #lungcancer awareness campaign.
It was developed by jointly by ALK+ UK, EGFR+ UK & the Ruth Strauss Foundation to encourage HCPs to consider lung cancer in people with persistent or unexplained symptoms. #LCSM
Burnout isn’t about individual resilience. It’s about the conditions we create.
Our latest blog shares four practical actions from clinical leaders on how to rebuild control, trust and wellbeing across health and care.
Read the blog and join the movement – https://bit.ly/40zYhpM
We’re excited to be working with @britsciassoc.bsky.social to co-lead EDIS, a coalition working to improve equality, diversity and inclusion in science and health research.
Find out more about the plans for EDIS's next chapter ⤵️ www.crick.ac.uk/news/2026-03...
Hear more about the proposals for a bold and ambitious new approach to UK pharmacy professional leadership and have your say. Join one of the webinars from The UK Pharmacy Professional Leadership Advisory Board.
www.eventbrite.com/cc/next-step...
We’ll be in Edinburgh this week for #BTOG26. Debra Montague, our Chair, will be there following the latest discussions in thoracic oncology.
For people living with ALK+ #lungcancer, the conversation around brain mets, resistance, treatment sequencing & access to next-line options is critical. #LCSM
ALK+ #lungcancer often means staying on a TKI for years. If radiotherapy is needed for brain metastases or a growing spot, the big question is whether to continue the drug.
New ESMO–ESTRO guidance says combining them can increase side effects. #LCSM
www.sciencedirect.com/science/arti...
3.5M people in the UK are living with a rare disease. ALK+ #lungcancer is one of them.
On #RareDiseaseDay, we stand with everyone living with ALK+ & with the wider rare disease community calling for earlier diagnosis, equitable access to testing & treatment, & consistent specialist care. #LCSM
1 in 10 adults in the UK have been affected by misinformation.
That rises to 2 in 10 for black and ethnic minority communities.
In our new video in partnership with
@england.nhs.uk, Dr Sylvia Kama-Kieghe talks about what you can do to find trusted health information.
youtube.com/shorts/A9b6O...
A group of people engaged in conversation at a conference event. Visible in the background are banners featuring the logos of Bath Spa University and other sponsors. The setting is a modern indoor venue with large windows.
Looking to connect with the people shaping health and care?
Find out more about our partnership packages and wider opportunities, contact partnerships@kingsfund.org.uk or book a call with our Corporate Sponsorships Manager, Donna Maher. https://bit.ly/4czt8Ki
When brain metastases are present at diagnosis in ALK+ #lungcancer, 1st treatment choice is critical.
New meta-analysis of 8 RCTs shows next-gen ALK TKIs, especially lorlatinib, give stronger control in the brain. In the UK lorlatinib is now first line.
www.tandfonline.com/doi/full/10.... #LCSM
The Guardian reports concerns about AI health summaries appearing at the top of search results without clear safety warnings.
When someone searches “Could it be lung cancer?” they need accurate, reviewed information.
We’re @pifonline.bsky.social certified - evidence-based & independently assessed.
Being told you’re ALK+ can feel like another layer on top of an already overwhelming #lungcancer diagnosis.
ALK+ means the cancer has a specific gene change driving it. That can guide the right treatment path & can open up options like targeted therapy. #LCSM
Graph depicting confidence over ability to find trustworthy information about certain topics
Graph depicting top sources of medical information
Graph showing what makes people unlikely to trust a source of medical information
1/2 - Confidence among UK adults in recognising accurate health information is not widespread.
Almost 6 in 10 people feel confident in their ability to identify trustworthy medical information.
But nearly half the population is uncertain about whether the advice they find is reliable.
Congratulations to @charlesswanton.bsky.social on being awarded the Sjöberg Prize Laureate from @scienceacademyswe.bsky.social.
Read more about the award and Charlie’s work on the clonal evolution of cancer cells and its importance for tumour growth and metastasis:
www.crick.ac.uk/news/2026-02...
High responsibility and low control can lead to burnout. Sharon Nash shares some reflections from clinical leaders on how organisations can prioritise the health and wellbeing of staff in her new blog.
https://bit.ly/406OhEa
@caswelldrm.bsky.social is lead author of a recent opinion paper bringing tog evidence on how #lungcancer in never smokers differs in its biology & risk profile.
People with no smoking history now account for a growing share of diagnoses. UK data show cases in never-smokers doubling 2008-14. #LCSM
Feels nuts that this is even a standard!
Time critical...
24 hours...
Massive cuts to global health-care funding have had a huge impact on Africa, but a more resilient system can be built from within
go.nature.com/46RnW0G
🆕 2024 data from the @nlca-natcan.bsky.social State of the Nation 2026 report shows women now account for > 1/2 of lung cancer diagnoses in England.
Around 1 in 10 diagnosed have never smoked. #Lungcancer is changing. National reporting must keep pace.
www.natcan.org.uk/wp-content/u...
#LCSM
